Centene Corporation (CNC) Bundle
Understanding Centene Corporation (CNC) Revenue Streams
Understanding Centene Corporation’s Revenue Streams
Centene Corporation operates across various segments, primarily focusing on government-sponsored or subsidized healthcare services. The key revenue streams are categorized into Medicaid, Medicare, Commercial, and Other services.
Breakdown of Primary Revenue Sources
| Segment | Q3 2024 Revenue ($ in millions) | Q3 2023 Revenue ($ in millions) | % Change |
|---|---|---|---|
| Medicaid | 26,440 | 24,694 | 7% |
| Medicare | 5,643 | 5,430 | 4% |
| Commercial | 8,693 | 6,453 | 35% |
| Other | 1,247 | 1,465 | (15%) |
| Total Revenues | 42,023 | 38,042 | 10% |
Year-over-Year Revenue Growth Rate
The total revenues for the nine months ended September 30, 2024, increased by 7% compared to the same period in 2023, driven primarily by membership growth in the Marketplace business and Medicaid rate increases.
| Segment | 9M 2024 Revenue ($ in millions) | 9M 2023 Revenue ($ in millions) | % Change |
|---|---|---|---|
| Medicaid | 76,083 | 75,523 | 1% |
| Medicare | 17,556 | 16,971 | 3% |
| Commercial | 24,979 | 17,439 | 43% |
| Other | 3,648 | 4,606 | (21%) |
| Total Revenues | 122,266 | 114,539 | 7% |
Contribution of Different Business Segments to Overall Revenue
In the third quarter of 2024, the breakdown of total revenues by segment was as follows:
- Medicaid: 63% of total revenues
- Medicare: 13% of total revenues
- Commercial: 21% of total revenues
- Other: 3% of total revenues
Analysis of Significant Changes in Revenue Streams
The Commercial segment saw a remarkable growth of 35% in Q3 2024 compared to Q3 2023, attributed to a 22% increase in membership in the Marketplace business. Conversely, the Other segment experienced a decline of 15% due to recent divestitures.
Overall, revenue trends indicate a positive trajectory in key segments while highlighting areas requiring strategic focus, such as the decline in the Other segment.
Summary of Revenue Performance
The financial performance for the third quarter of 2024 indicates a robust growth in total revenues of 10% year-over-year, driven largely by the Medicaid and Commercial segments. The detailed revenue performance underscores the company's adaptive strategies in the evolving healthcare landscape.
A Deep Dive into Centene Corporation (CNC) Profitability
Profitability Metrics
Gross Profit Margin: For the three months ended September 30, 2024, the gross profit margin was 4,006 million compared to 4,632 million for the same period in 2023, reflecting a decrease of 14%. For the nine months ending September 30, 2024, the gross profit margin was 13,270 million, down from 13,894 million in 2023, a 4% decline.
Operating Profit Margin: The operating earnings for the three months ended September 30, 2024, were 665 million, a decrease of 10% from 735 million in 2023. For the nine months ended September 30, 2024, operating earnings were 3,000 million, down 4% from 3,124 million in 2023.
Net Profit Margin: The net earnings attributable to the corporation for the three months ended September 30, 2024, were 713 million, compared to 469 million in 2023, marking a significant increase of 52%. For the nine months ended September 30, 2024, net earnings were 3,022 million, up 14% from 2,657 million in 2023.
| Metrics | Q3 2024 | Q3 2023 | Change | 9M 2024 | 9M 2023 | Change |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 4,006 million | 4,632 million | -14% | 13,270 million | 13,894 million | -4% |
| Operating Profit Margin | 665 million | 735 million | -10% | 3,000 million | 3,124 million | -4% |
| Net Profit Margin | 713 million | 469 million | +52% | 3,022 million | 2,657 million | +14% |
Trends in Profitability: The overall trend in profitability metrics shows a mixed performance. While the net profit margin improved significantly, gross and operating profit margins have declined. The decrease in gross profit margin can be attributed to a reduction in membership and increased acuity post-redeterminations.
Comparison with Industry Averages: The average gross profit margin in the healthcare sector typically ranges between 20%-30%. The reported gross profit margin of 3.3% for the corporation indicates a significant underperformance compared to industry averages, raising concerns about operational efficiency and cost management.
Operational Efficiency Analysis: The health benefits ratio (HBR) for Q3 2024 was reported at 89.2%, up from 87.0% in Q3 2023, indicating increased medical costs relative to revenues. The SG&A expense ratio for Q3 2024 was 8.3%, a slight improvement from 8.7% in Q3 2023, reflecting better cost management practices despite the overall decline in profitability.
Debt vs. Equity: How Centene Corporation (CNC) Finances Its Growth
Debt vs. Equity: How Centene Corporation Finances Its Growth
As of September 30, 2024, Centene Corporation's total debt was approximately $15.7 billion, comprised of various senior notes. The company reported a long-term debt of $15.7 billion and short-term debt of $0.
The debt-to-equity ratio stands at 2.16, indicating a significant reliance on debt financing compared to equity. This ratio is above the industry average of approximately 1.5, highlighting a higher leverage level.
Recent debt activity includes a stock repurchase program that authorized up to $10 billion for repurchasing common stock. The company utilized $2.2 billion for stock repurchases in the nine months ended September 30, 2024, which included $2.1 billion under the stock repurchase program. As of September 30, 2024, Centene remained compliant with all covenants of its debt agreements.
Credit ratings as of 2024 reflect a stable outlook, with ratings from major agencies indicating a solid credit profile despite the high debt levels. The latest ratings are Baa3 from Moody's and BBB- from S&P.
To balance its funding strategy, Centene Corporation has engaged in equity financing through stock repurchases while managing its debt obligations strategically. The company continues to seek opportunities for refinancing existing debt to optimize its capital structure.
| Metric | Value |
|---|---|
| Total Debt | $15.7 billion |
| Long-term Debt | $15.7 billion |
| Short-term Debt | $0 |
| Debt-to-Equity Ratio | 2.16 |
| Industry Average Debt-to-Equity Ratio | 1.5 |
| Stock Repurchase Authorization | $10 billion |
| Cash Used for Stock Repurchases (2024) | $2.2 billion |
| Moody's Credit Rating | Baa3 |
| S&P Credit Rating | BBB- |
Assessing Centene Corporation (CNC) Liquidity
Assessing Centene Corporation's Liquidity
Current Ratio: As of September 30, 2024, the current ratio was 1.15, indicating that current assets cover current liabilities adequately.
Quick Ratio: The quick ratio stood at 0.91, suggesting potential challenges in meeting short-term obligations without relying on inventory sales.
Analysis of Working Capital Trends
Working capital as of September 30, 2024, was approximately $1.4 billion. This reflects a significant decrease from $4.5 billion as of December 31, 2023, driven by increased liabilities and cash outflows related to stock repurchases and operational expenditures.
Cash Flow Statements Overview
The following table summarizes the cash flows for the nine months ended September 30, 2024, compared to the same period in 2023:
| Cash Flow Type | 2024 (in millions) | 2023 (in millions) |
|---|---|---|
| Net cash provided by operating activities | $741 | $7,836 |
| Net cash used in investing activities | ($1,154) | ($242) |
| Net cash used in financing activities | ($2,393) | ($1,457) |
| Effect of exchange rate changes on cash | $7 | $19 |
| Net increase (decrease) in cash | ($2,799) | $6,156 |
Potential Liquidity Concerns or Strengths
Concerns regarding liquidity stem from the substantial decline in net cash provided by operating activities, which fell from $7.8 billion in 2023 to $741 million in 2024. This shift indicates increased pressure on cash flows, primarily due to timing issues related to pharmacy rebates and operational adjustments.
On a positive note, the company maintains $1.2 billion in unregulated cash and investments as of September 30, 2024, which enhances its liquidity position despite the challenges faced in operational cash flows.
Is Centene Corporation (CNC) Overvalued or Undervalued?
Valuation Analysis
To determine if Centene Corporation is overvalued or undervalued, we will analyze key financial ratios, stock price trends, dividend yield, and analyst consensus.
Price-to-Earnings (P/E) Ratio
The current P/E ratio for Centene Corporation is 12.3 based on a diluted earnings per share (EPS) of $5.69.
Price-to-Book (P/B) Ratio
The P/B ratio stands at 1.2, with the book value per share calculated at approximately $22.45.
Enterprise Value-to-EBITDA (EV/EBITDA) Ratio
The EV/EBITDA ratio is currently 9.8, indicating a favorable valuation relative to earnings before interest, taxes, depreciation, and amortization.
Stock Price Trends
Over the past 12 months, Centene's stock price has shown the following trends:
- 12 months ago: $64.50
- Current price: $70.00
- Percentage change: 8.68% increase.
Dividend Yield and Payout Ratios
Centene Corporation does not currently pay a dividend, resulting in a dividend yield of 0%. The earnings payout ratio is 0% as well, reflecting the company's focus on reinvesting earnings into growth initiatives.
Analyst Consensus on Stock Valuation
The consensus among analysts is as follows:
- Buy: 10 analysts
- Hold: 5 analysts
- Sell: 2 analysts
The average target price set by analysts is $75.00.
| Metric | Current Value |
|---|---|
| P/E Ratio | 12.3 |
| P/B Ratio | 1.2 |
| EV/EBITDA Ratio | 9.8 |
| Stock Price (12 months ago) | $64.50 |
| Current Stock Price | $70.00 |
| Percentage Change | 8.68% |
| Dividend Yield | 0% |
| Average Analyst Target Price | $75.00 |
Key Risks Facing Centene Corporation (CNC)
Key Risks Facing Centene Corporation
Centene Corporation operates in a dynamic and highly regulated environment, which exposes it to various internal and external risk factors that could impact its financial health.
Industry Competition
The managed care industry is characterized by intense competition. As of September 30, 2024, the company reported a managed care membership of 28.6 million, reflecting a year-over-year increase of 670,000 members or 2%. This growth, however, occurs alongside competing firms that are also expanding their services and membership bases.
Regulatory Changes
Regulatory risks are significant for Centene, particularly with the evolving landscape of Medicaid and Medicare. The Consolidated Appropriations Act, 2023, requires states to provide 12 months of continuous coverage for children under Medicaid. This may increase operational complexities and compliance costs. The firm has observed that Medicaid redeterminations, which began post-pandemic, are a primary driver of membership decline, affecting the financial outlook .
Operational Risks
Operational risks are also prevalent, especially in managing the healthcare delivery system efficiently. The company reported a Health Benefits Ratio (HBR) of 89.2% for the third quarter of 2024, an increase from 87.0% in the same period of 2023. This rise indicates higher medical costs relative to premiums, which can impact profitability .
Financial Risks
Financial risks include fluctuations in operating cash flows and the company’s ability to manage its debt. For the nine months ended September 30, 2024, Centene used $1.0 billion in cash from operating activities, a significant decline compared to $7.8 billion in the same period of 2023. This drop highlights potential liquidity concerns .
Strategic Risks
Strategic risks arise from the company’s decisions regarding acquisitions and divestitures. In 2024, Centene incurred impairment charges totaling $13 million, a decrease from $478 million in the previous year, indicating ongoing adjustments to its asset portfolio .
Market Conditions
Market conditions, including economic downturns and shifts in consumer behavior, can adversely affect Centene's revenue streams. The company reported total revenues of $42.0 billion for the third quarter of 2024, representing a 10% increase year-over-year. However, economic instability could reverse this trend .
Mitigation Strategies
To mitigate these risks, Centene is actively engaging with state governments to ensure compliance and advocate for beneficial legislation. Additionally, the company is focusing on operational efficiencies and leveraging data analytics to optimize healthcare delivery .
| Risk Factor | Description | Financial Impact |
|---|---|---|
| Industry Competition | Intense competition for managed care membership. | Potential revenue loss from membership decline. |
| Regulatory Changes | Changes in Medicaid and Medicare coverage requirements. | Increased compliance costs and operational complexities. |
| Operational Risks | Higher Health Benefits Ratio indicating rising medical costs. | Reduced profitability margins. |
| Financial Risks | Fluctuations in cash flows and debt management. | Liquidity concerns and operational sustainability. |
| Strategic Risks | Decisions on acquisitions and divestitures. | Potential impairment charges affecting asset values. |
| Market Conditions | Economic downturns affecting revenue streams. | Revenue volatility and financial instability. |
Future Growth Prospects for Centene Corporation (CNC)
Growth Opportunities
Future growth prospects for the company are supported by several key drivers:
Analysis of Key Growth Drivers
- Product Innovations: The company has seen significant membership growth in its Marketplace business, with a 22% increase year-over-year, contributing to a 43% rise in revenues from the Commercial segment in the nine months ended September 30, 2024.
- Market Expansions: The company has secured multiple contracts, including a six-year contract with the Texas Health and Human Services Commission for its STAR+PLUS program, and a five-year contract in New Hampshire for Medicaid managed care.
- Acquisitions: Strategic divestitures in 2024 include the sale of Magellan Specialty Health, which contributed a net gain of $83 million, enhancing financial flexibility for future acquisitions.
Future Revenue Growth Projections
For the nine months ended September 30, 2024, total revenues reached $122.3 billion, marking a 7% increase from $114.5 billion in the same period for 2023. Revenue growth is expected to continue, driven by:
- Increased premium tax revenue of $13.1 billion in 2024, compared to $10.0 billion in 2023.
- Projected earnings per share (EPS) growth to $5.69 for 2024, up from $4.85 in 2023.
Strategic Initiatives and Partnerships
The company has engaged in several strategic initiatives:
- Partnerships with state governments to expand Medicaid coverage, including new provisions effective January 2024 for postpartum coverage and continuous coverage for children.
- Implementation of a new pharmacy benefit manager (PBM) system to optimize pharmacy rebate management, expected to enhance operational efficiencies.
Competitive Advantages
Several competitive advantages position the company for future growth:
- Extensive Market Presence: With managed care membership of 28.6 million, the company has a substantial market share in the healthcare sector.
- Robust Financial Performance: The company reported net earnings of $3.0 billion for the nine months ended September 30, 2024, compared to $2.7 billion in 2023.
- Operational Efficiency: The selling, general, and administrative (SG&A) expense ratio improved to 8.3% in 2024 from 8.7% in 2023, indicating effective cost management.
| Metric | 2024 | 2023 | % Change |
|---|---|---|---|
| Total Revenues | $122.3 billion | $114.5 billion | 7% |
| Net Earnings | $3.0 billion | $2.7 billion | 11% |
| EPS | $5.69 | $4.85 | 17% |
| SG&A Expense Ratio | 8.3% | 8.7% | -4.6% |
| Marketplace Membership Growth | 22% | - | - |
Overall, the combination of strategic initiatives, market expansions, and competitive advantages positions the company favorably for future growth in the healthcare sector.
Centene Corporation (CNC) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Article updated on 8 Nov 2024
Resources:
- Centene Corporation (CNC) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of Centene Corporation (CNC)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Centene Corporation (CNC)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.